2004
DOI: 10.1016/s1572-1000(04)00005-5
|View full text |Cite
|
Sign up to set email alerts
|

Autofluorescence (safe) bronchoscopy and p21/ki-67 immunostaining related to carcinogenesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2015
2015
2015
2015

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 30 publications
0
1
0
Order By: Relevance
“…The discovery of in situ endobronchial cancer and early detection of the local recurrence are greatly assisted by autofluorescence bronchoscopy, which can provide localization of the lesion in cases where the lesion may not be visible by the usual white light bronchoscopy. [60][61][62] Over 95% of PDTs in lung cancer are performed bronchoscopically for central-type lung cancer and usually for nonsmall cell lung cancer histology. Bronchoscopic PDT is performed in the usual two steps, that is, systemic presensitization followed by an interval of illumination using the bronchoscope's instrumental channel to accommodate the laser delivery fiber.…”
Section: Head and Neckmentioning
confidence: 99%
“…The discovery of in situ endobronchial cancer and early detection of the local recurrence are greatly assisted by autofluorescence bronchoscopy, which can provide localization of the lesion in cases where the lesion may not be visible by the usual white light bronchoscopy. [60][61][62] Over 95% of PDTs in lung cancer are performed bronchoscopically for central-type lung cancer and usually for nonsmall cell lung cancer histology. Bronchoscopic PDT is performed in the usual two steps, that is, systemic presensitization followed by an interval of illumination using the bronchoscope's instrumental channel to accommodate the laser delivery fiber.…”
Section: Head and Neckmentioning
confidence: 99%